Literature DB >> 29395516

Haemophilus influenzae-protein D specific antibody correlate with protection against acute otitis media in young children.

Anthony Almudevar1, Michael E Pichichero2.   

Abstract

BACKGROUND: Haemophilus influenzae (Hi) causes respiratory infections and pathogenesis of this microbe begins in the human nasopharynx (NP). The objective of this study was to assess the correlation of NP colonization-induced serum antibody levels to Hi protein D with risk of acute otitis media (AOM) in children <2 yr.
METHODS: 455 sera from 213 children (age 6-24 months old) were collected when they were colonized with Hi and when the children developed AOM. Presence of Hi during AOM was confirmed by culture of middle ear fluid. Quantitative ELISA was used to determine serum IgG against protein D antigen.
RESULTS: Asymptomatic Hi NP colonization reduced the risk of future AOM infections. Higher serum IgG titers against Hi protein D were correlated with reduced future AOM risk.
CONCLUSION: Colonization by Hi reduces future AOM risk. Higher antibody levels against protein D correlates with lower risk of AOM caused by Hi.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Antibody response; Correlate of protection; Haemophilus influenzae

Mesh:

Substances:

Year:  2018        PMID: 29395516      PMCID: PMC6219858          DOI: 10.1016/j.vaccine.2018.01.021

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  12 in total

Review 1.  Dynamics of nasopharyngeal colonization by potential respiratory pathogens.

Authors:  J A García-Rodríguez; M J Fresnadillo Martínez
Journal:  J Antimicrob Chemother       Date:  2002-12       Impact factor: 5.790

Review 2.  Ten-Year Study of the Stringently Defined Otitis-prone Child in Rochester, NY.

Authors:  Michael E Pichichero
Journal:  Pediatr Infect Dis J       Date:  2016-09       Impact factor: 2.129

3.  Antibody response to Haemophilus influenzae outer membrane protein D, P6, and OMP26 after nasopharyngeal colonization and acute otitis media in children.

Authors:  Michael E Pichichero; Ravinder Kaur; Janet R Casey; Albert Sabirov; M Nadeem Khan; Anthony Almudevar
Journal:  Vaccine       Date:  2010-08-26       Impact factor: 3.641

Review 4.  Microbiology of bacterial respiratory infections.

Authors:  D Cappelletty
Journal:  Pediatr Infect Dis J       Date:  1998-08       Impact factor: 2.129

5.  New patterns in the otopathogens causing acute otitis media six to eight years after introduction of pneumococcal conjugate vaccine.

Authors:  Janet R Casey; Diana G Adlowitz; Michael E Pichichero
Journal:  Pediatr Infect Dis J       Date:  2010-04       Impact factor: 2.129

Review 6.  Ten-Year Study of Acute Otitis Media in Rochester, NY.

Authors:  Michael E Pichichero
Journal:  Pediatr Infect Dis J       Date:  2016-09       Impact factor: 2.129

Review 7.  Streptococcus pneumoniae colonisation: the key to pneumococcal disease.

Authors:  D Bogaert; R De Groot; P W M Hermans
Journal:  Lancet Infect Dis       Date:  2004-03       Impact factor: 25.071

Review 8.  Microbial interactions in the respiratory tract.

Authors:  Timothy F Murphy; Lauren O Bakaletz; Pierre R Smeesters
Journal:  Pediatr Infect Dis J       Date:  2009-10       Impact factor: 2.129

Review 9.  Impact of protein D-containing pneumococcal conjugate vaccines on non-typeable Haemophilus influenzae acute otitis media and carriage.

Authors:  Christopher Clarke; Lauren O Bakaletz; Javier Ruiz-Guiñazú; Dorota Borys; Tomas Mrkvan
Journal:  Expert Rev Vaccines       Date:  2017-06-07       Impact factor: 5.217

10.  Variability and diversity of nasopharyngeal microbiota in children: a metagenomic analysis.

Authors:  Debby Bogaert; Bart Keijser; Susan Huse; John Rossen; Reinier Veenhoven; Elske van Gils; Jacob Bruin; Roy Montijn; Marc Bonten; Elisabeth Sanders
Journal:  PLoS One       Date:  2011-02-28       Impact factor: 3.240

View more
  2 in total

Review 1.  Panel 8: Vaccines and immunology.

Authors:  Mark R Alderson; Tim Murphy; Stephen I Pelton; Laura A Novotny; Laura L Hammitt; Arwa Kurabi; Jian-Dong Li; Ruth B Thornton; Lea-Ann S Kirkham
Journal:  Int J Pediatr Otorhinolaryngol       Date:  2019-12-18       Impact factor: 1.675

2.  Interchangeability, immunogenicity and safety of a combined 10-valent pneumococcal Haemophilus influenzae protein D conjugate vaccine (Synflorix) and 13-valent-PCV (Prevenar13) schedule at 1-2-4-6 months: PREVIX_COMBO, a 3-arm randomised controlled trial.

Authors:  Amanda Jane Leach; Edward Kim Mulholland; Mathuram Santosham; Paul John Torzillo; Peter McIntyre; Heidi Smith-Vaughan; Nicole Wilson; Beth Arrowsmith; Jemima Beissbarth; Mark D Chatfield; Victor M Oguoma; Paul Licciardi; Sue Skull; Ross Andrews; Jonathan Carapetis; Joseph McDonnell; Vicki Krause; Peter Stanley Morris
Journal:  Vaccine X       Date:  2021-02-15
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.